Document is current
Any future updates will be listed below
-
Authors
Douaud, Gwenaëlle http://orcid.org/0000-0003-1981-391X
Lee, Soojin
Alfaro-Almagro, Fidel
Arthofer, Christoph http://orcid.org/0000-0003-1474-9963
Wang, Chaoyue http://orcid.org/0000-0001-9402-1563
McCarthy, Paul
Lange, Frederik http://orcid.org/0000-0002-1736-7162
Andersson, Jesper L. R.
Griffanti, Ludovica
Duff, Eugene
Jbabdi, Saad
Taschler, Bernd http://orcid.org/0000-0001-6574-4789
Keating, Peter
Winkler, Anderson M.
Collins, Rory
Matthews, Paul M. http://orcid.org/0000-0002-1619-8328
Allen, Naomi
Miller, Karla L.
Nichols, Thomas E. http://orcid.org/0000-0002-4516-5103
Smith, Stephen M. http://orcid.org/0000-0001-8166-069X
- License Information
-
More Information
Article History
Received: 19 August 2021
Accepted: 21 February 2022
First Online: 7 March 2022
Competing interests
: R.C. has been seconded from the University of Oxford as chief executive and principal investigator of UK Biobank, which is a charitable company. N.A. is chief scientist for UK Biobank. P.M.M. acknowledges consultancy fees from Novartis and Biogen; he has received recent honoraria or speakers’ honoraria and research or educational funds from Novartis, Bristol Myers Squibb and Biogen. P.M.M. serves as the honorary chair of the UK Biobank Imaging Working Group and as an unpaid member of the UK Biobank Steering Committee; he is chair of the UKRI Medical Research Council Neurosciences and Mental Health Board.
